9-136367753-C-G

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_052813.5(CARD9):​c.1153G>C​(p.Val385Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0202 in 1,605,422 control chromosomes in the GnomAD database, including 410 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 20 hom., cov: 34)
Exomes 𝑓: 0.021 ( 390 hom. )

Consequence

CARD9
NM_052813.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.106
Variant links:
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 9-136367753-C-G is Benign according to our data. Variant chr9-136367753-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 365838.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-136367753-C-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0133 (2031/152346) while in subpopulation NFE AF= 0.0231 (1573/68030). AF 95% confidence interval is 0.0222. There are 20 homozygotes in gnomad4. There are 930 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD9NM_052813.5 linkc.1153G>C p.Val385Leu missense_variant Exon 8 of 13 ENST00000371732.10 NP_434700.2 Q9H257-1A0A024R8F1
CARD9NM_052814.4 linkc.1153G>C p.Val385Leu missense_variant Exon 8 of 13 NP_434701.1 Q9H257-2
LOC124902309XR_007061863.1 linkn.214C>G non_coding_transcript_exon_variant Exon 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD9ENST00000371732.10 linkc.1153G>C p.Val385Leu missense_variant Exon 8 of 13 1 NM_052813.5 ENSP00000360797.5 Q9H257-1
ENSG00000289701ENST00000696169.1 linkn.*200G>C non_coding_transcript_exon_variant Exon 8 of 13 ENSP00000512460.1
ENSG00000289701ENST00000696169.1 linkn.*200G>C 3_prime_UTR_variant Exon 8 of 13 ENSP00000512460.1

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2031
AN:
152228
Hom.:
20
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00321
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.00628
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00703
Gnomad FIN
AF:
0.0128
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0231
Gnomad OTH
AF:
0.00956
GnomAD3 exomes
AF:
0.0145
AC:
3453
AN:
237458
Hom.:
51
AF XY:
0.0153
AC XY:
1989
AN XY:
129810
show subpopulations
Gnomad AFR exome
AF:
0.00447
Gnomad AMR exome
AF:
0.00367
Gnomad ASJ exome
AF:
0.00327
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0108
Gnomad FIN exome
AF:
0.0124
Gnomad NFE exome
AF:
0.0246
Gnomad OTH exome
AF:
0.0110
GnomAD4 exome
AF:
0.0209
AC:
30329
AN:
1453076
Hom.:
390
Cov.:
31
AF XY:
0.0208
AC XY:
15027
AN XY:
723250
show subpopulations
Gnomad4 AFR exome
AF:
0.00356
Gnomad4 AMR exome
AF:
0.00408
Gnomad4 ASJ exome
AF:
0.00341
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0121
Gnomad4 FIN exome
AF:
0.0123
Gnomad4 NFE exome
AF:
0.0246
Gnomad4 OTH exome
AF:
0.0165
GnomAD4 genome
AF:
0.0133
AC:
2031
AN:
152346
Hom.:
20
Cov.:
34
AF XY:
0.0125
AC XY:
930
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00320
Gnomad4 AMR
AF:
0.00627
Gnomad4 ASJ
AF:
0.00346
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00704
Gnomad4 FIN
AF:
0.0128
Gnomad4 NFE
AF:
0.0231
Gnomad4 OTH
AF:
0.00946
Alfa
AF:
0.0154
Hom.:
12
Bravo
AF:
0.0123
TwinsUK
AF:
0.0235
AC:
87
ALSPAC
AF:
0.0239
AC:
92
ESP6500AA
AF:
0.00479
AC:
21
ESP6500EA
AF:
0.0216
AC:
185
ExAC
AF:
0.0157
AC:
1891
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0232
EpiControl
AF:
0.0218

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CARD9: BS1, BS2 -

Predisposition to invasive fungal disease due to CARD9 deficiency Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

CARD9-related disorder Benign:1
Sep 09, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
14
DANN
Benign
0.89
DEOGEN2
Benign
0.21
.;T
Eigen
Benign
-0.98
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.82
T;T
MetaRNN
Benign
0.0070
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L;L
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-1.6
N;N
REVEL
Benign
0.083
Sift
Benign
0.058
T;T
Sift4G
Benign
0.24
T;T
Polyphen
0.0020
B;B
Vest4
0.69
MutPred
0.15
Loss of MoRF binding (P = 0.0901);Loss of MoRF binding (P = 0.0901);
MPC
0.078
ClinPred
0.0012
T
GERP RS
0.91
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.072
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.21
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.21
Position offset: -41

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3124993; hg19: chr9-139262205; API